Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis
- 30 November 2008
- journal article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 9 (11), 1039-1047
- https://doi.org/10.1016/s1470-2045(08)70235-3
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Risk factors for prostate cancer incidence and progression in the health professionals follow‐up studyInternational Journal of Cancer, 2007
- Anthropometrics and Prostate Cancer RiskAmerican Journal of Epidemiology, 2007
- Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortalityCancer, 2007
- Body Mass Index, Weight Change, and Risk of Prostate Cancer in the Cancer Prevention Study II Nutrition CohortCancer Epidemiology, Biomarkers & Prevention, 2007
- Body size and composition and prostate cancer risk: systematic review and meta-regression analysisCancer Causes & Control, 2006
- Impact of obesity on prostate cancer recurrence after radical prostatectomy: Data from CaPSUREUrology, 2005
- Obesity, Weight Gain, and Risk of Biochemical Failure among Prostate Cancer Patients following ProstatectomyClinical Cancer Research, 2005
- Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomyCancer, 2005
- Impact of Obesity on Biochemical Control After Radical Prostatectomy for Clinically Localized Prostate Cancer: A Report by the Shared Equal Access Regional Cancer Hospital Database Study GroupJournal of Clinical Oncology, 2004
- Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical ProstatectomyJournal of Clinical Oncology, 2004